Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqCM - Nasdaq Real Time Price USD

Mangoceuticals, Inc. (MGRX)

Compare
1.8894
+0.0694
+(3.75%)
As of 10:23:00 AM EDT. Market Open.
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for MGRX

Recent News: MGRX

View More
Mangoceuticals Expands into $33 Billion Addressable Diabetes Market Through its Exclusive Rights to Market and Sell Patented and Clinically Proven Diabetinol® in the USA and Canada

Mangoceuticals Expands into $33 Billion Addressable Diabetes Market Through its Exclusive Rights to Market and Sell Patented and Clinically Proven Diabetinol® in the USA and Canada
GlobeNewswire 21 days ago
Mangoceuticals Announces the Launch of “PeachesRx” - a Women's Telehealth Brand Focused on Personalized Wellness and GLP-1 Weight Loss Treatments

Mangoceuticals Announces the Launch of “PeachesRx” - a Women's Telehealth Brand Focused on Personalized Wellness and GLP-1 Weight Loss Treatments
GlobeNewswire last month
Mangoceuticals Advances Antiviral Research on its Patented Respiratory Illness Prevention Technology With New Study Targeting Avian Flu in Poultry Using a Non-Invasive, Non-Pharmaceutical Water-Based Solution

Mangoceuticals Advances Antiviral Research on its Patented Respiratory Illness Prevention Technology With New Study Targeting Avian Flu in Poultry Using a Non-Invasive, Non-Pharmaceutical Water-Based Solution
GlobeNewswire 2 months ago
Mangoceuticals Advances H1N1 Efficacy Study Noting Significant Reduction in Viral Load in Phase 1 Studies and Engages Vipragen Biosciences to Structure H5N1 Cohort for Expanded Research

Mangoceuticals Advances H1N1 Efficacy Study Noting Significant Reduction in Viral Load in Phase 1 Studies and Engages Vipragen Biosciences to Structure H5N1 Cohort for Expanded Research
GlobeNewswire 2 months ago
Mangoceuticals, Inc. Executes Exclusive Distribution Agreement with Propre Energie for Clinically Proven Dermytol®️ Skincare Treatment Targeting Hyperpigmentation

Mangoceuticals, Inc. Executes Exclusive Distribution Agreement with Propre Energie for Clinically Proven Dermytol®️ Skincare Treatment Targeting Hyperpigmentation
GlobeNewswire 2 months ago
Mangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations Patent

Mangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations Patent
GlobeNewswire 3 months ago
Mangoceuticals, Inc. Initiates Investigation into Potential Stock Manipulation Scheme Following Recent Reverse Stock Split

Mangoceuticals, Inc. Initiates Investigation into Potential Stock Manipulation Scheme Following Recent Reverse Stock Split
GlobeNewswire 4 months ago
Mangoceuticals, Inc. Regains Full Compliance with Nasdaq Minimum Bid Price Requirement

Mangoceuticals, Inc. Regains Full Compliance with Nasdaq Minimum Bid Price Requirement
GlobeNewswire 5 months ago
MangoRx Announces Formation of Strategy and Alternatives Committee

MangoRx Announces Formation of Strategy and Alternatives Committee
GlobeNewswire 5 months ago
MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly

MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly
GlobeNewswire 5 months ago

Mangoceuticals, Inc. Announces Participation at the Centurion One Capital 2nd Annual Bahamas Summit 2024
Newsfile 5 months ago
View More

Related Tickers

MNDR Mobile-health Network Solutions
1.5200
-1.94%
 
ONMD OneMedNet Corporation
0.5001
+0.02%
 
VSEE VSee Health, Inc.
1.0721
+0.19%
 
ACON Aclarion, Inc.
10.01
+0.10%
 
AINO.ST Aino Health AB (publ)
0.2000
+42.86%
 
EMOR Healixa Inc.
0.0200
+33.33%
 
FOXO FOXO Technologies Inc.
0.1098
-3.68%
 
HYDTF Hydreight Technologies Inc.
1.2200
+3.39%
 
LGMK LogicMark, Inc.
0.0117
-10.69%
 
DRIO DarioHealth Corp.
0.7051
+5.02%